How to Market a Peptide Company When Ads Are Restricted

Start from the constraint

Meta, Google, and TikTok all have policies restricting or prohibiting advertising in this category. The written policy is not the whole story. What operators actually report is inconsistent enforcement — accounts approved one month and disabled the next, appeals that go nowhere, and audiences that vanish with the account.

Some operators do run paid successfully, usually on carefully worded brand-level campaigns that avoid the restricted territory entirely. Almost none of them treat it as their foundation, because a channel that can be switched off without notice or recourse is not a foundation.

The strategic conclusion follows directly: paid is an accelerant on top of something that works without it. If your plan requires ads to be viable, you have a single point of failure controlled by a company with no obligation to you. Build the owned channels first and treat paid as an experiment funded by revenue.

Channel 1: search and content

The highest-leverage channel available, for two reasons. The buyer is actively looking, which means intent is high. And nobody can switch it off — a page that ranks keeps working whether or not a platform likes your category.

The cost is time. Three to six months before meaningful traffic, longer for competitive commercial terms. That timeline is fixed regardless of when you start, which makes starting late a pure loss with no compensating benefit. The most common regret we hear is not about what someone published — it is about when they started.

Sequence commercial intent first. The pages that convert are the ones answering “what does this cost”, “how does this work”, “who does this for me”, and “X versus Y”. Informational content is worth publishing, but its job is to support the commercial pages through internal linking, not to chase traffic for its own sake.

• Ten commercial-intent pages before any informational content
• One page per intent — two pages targeting the same query cannibalize each other
• Named authors and real organizational information, because health-adjacent queries face heightened quality evaluation
• Internal links from every supporting article to the commercial page it supports
• No purchased links, private blog networks, or bulk AI content — the risk lands on your domain

Channel 2: email

The only audience you own outright. Every other channel is rented, and in this category the landlord can evict you. A list built from your site, your existing clients, and your content is portable, unrestricted, and typically the highest-converting asset an operator has.

Build the capture mechanism on day one, even if you have nothing to send yet. The cost of collecting addresses you do not use is zero; the cost of not collecting addresses for six months is six months of compounding.

The mechanism matters more than the offer. A genuinely useful resource — a checklist, a cost breakdown, a comparison document — outperforms a discount, because the people who want a discount and the people who want to understand the category are different people, and only one of them becomes a customer.

Channel 3: referral and partnership

In a trust-sensitive category, a recommendation from a practitioner, a supplier, or an existing client outperforms any advertisement by a wide margin. It is also the most under-built channel we see, for a simple reason: it cannot be automated, so nobody owns it.

Make it a named person's job with a cadence. A list of specific target relationships, a defined outreach sequence, and a follow-up rhythm. Not “we should do more partnerships” — a spreadsheet with names and dates.

The highest-yield version is usually adjacent professionals rather than direct competitors: practitioners who see your buyer for something else, suppliers whose customers need what you offer, consultants who advise your market. These relationships take months to produce anything and then produce steadily.

Channel 4: direct and relationship sales

For B2B models — distribution, wholesale, white-label supply — this is usually the whole go-to-market, and the website's role is narrower than people expect. It is not there to close. It is there to make the operator look credible enough that a meeting happens and that due diligence does not stall.

Which means the pages that matter for a B2B model are the unglamorous ones: capabilities, documentation, policies, who runs the business. A beautiful home page with a thin About page loses deals that a plain home page with a substantial capabilities section wins.

Direct outreach works in this category precisely because the ad channels are closed — your competitors are also unable to buy their way in front of the same buyer.

A ninety-day sequence

The claims line runs through everything

A careful website paired with an uncareful email sequence is not a careful business, and the email is what gets screenshotted. The line has to hold identically across the site, email, social, sales conversations, and anything a staff member posts.

The line itself: describe the business, the process, the structure, and the people. Do not describe outcomes, effects, or comparisons to prescription products. It is narrower than most marketers are used to working in, and making it persuasive anyway is a craft problem rather than a compliance problem — once you stop trying to negotiate the constraint.

Write it down, share it with everyone who writes anything on your behalf, and review it with counsel. The version that lives in one person's head does not survive that person taking a holiday.

What to measure, and what to ignore

• Measure: qualified inquiries per week, by source. This is the only number that reliably predicts revenue.
• Measure: conversion rate from page view to form submission, per page. It tells you which pages to rewrite.
• Measure: time from inquiry to first response. It is the cheapest thing to fix and it moves close rates more than almost anything else.
• Ignore: raw traffic. Traffic from informational queries in a health-adjacent category rarely converts and inflates every other number.
• Ignore: social followers. In this category, an audience on a platform that restricts you is a liability dressed as an asset.
• Ignore: rankings for terms nobody with intent searches. A number one position on a zero-value query is a vanity metric with a spreadsheet.